ThermoFisher Oncomine Dx Target Test for Non-Small Cell Lung Cancer, Coding and Billing Guidelines

The Oncomine Dx Target Test (Thermo Fisher Scientific, Inc., Waltham, MA) is a 23 gene panel including 3 gene targets approved by the FDA for non-small cell lung cancer from tissue specimens¹. The test can simultaneously identify three gene variants that are key to targeted therapy selection: EGFR, BRAF and ROS1.

Source: https://www.palmettogba.com/palmetto/moldx.nsf/docsCat/MolDx Website~MolDx~Browse By Topic~Covered Tests